TAWNI HOWARD: Open Payments
NPI 1912363342 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 5 companies in 2025. Trend: 2023 $162 · 2024 $755 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: ABILIFY MAINTENA, COBENFY, VRAYLAR, AUSTEDO XR, REXULTI, INGREZZA, UZEDY.
Industry payments across NE — which companies pay providers there.
